Tower Research Capital (TRC)’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664 | Buy |
+145
| New | +$664 | ﹤0.01% | 4968 |
|
|
2025
Q1 | – | Sell |
-1,036
| Closed | -$6.96K | – | 5528 |
|
|
2024
Q4 | $6.96K | Buy |
1,036
+47
| +5% | +$316 | ﹤0.01% | 4119 |
|
|
2024
Q3 | $7.64K | Sell |
989
-1,317
| -57% | -$10.2K | ﹤0.01% | 4033 |
|
|
2024
Q2 | $13.8K | Buy |
2,306
+1,653
| +253% | +$9.92K | ﹤0.01% | 3972 |
|
|
2024
Q1 | $5.89K | Sell |
653
-495
| -43% | -$4.47K | ﹤0.01% | 4471 |
|
|
2023
Q4 | $10.9K | Buy |
1,148
+101
| +10% | +$957 | ﹤0.01% | 4190 |
|
|
2023
Q3 | $12.5K | Sell |
1,047
-1,651
| -61% | -$19.7K | ﹤0.01% | 3889 |
|
|
2023
Q2 | $66.1K | Buy |
2,698
+827
| +44% | +$20.3K | ﹤0.01% | 2332 |
|
|
2023
Q1 | $59K | Buy |
1,871
+1,758
| +1,556% | +$55.4K | ﹤0.01% | 2351 |
|
|
2022
Q4 | $8K | Sell |
113
-565
| -83% | -$40K | ﹤0.01% | 4414 |
|
|
2022
Q3 | $58K | Buy |
678
+319
| +89% | +$27.3K | ﹤0.01% | 3023 |
|
|
2022
Q2 | $30K | Sell |
359
-302
| -46% | -$25.2K | ﹤0.01% | 3381 |
|
|
2022
Q1 | $110K | Buy |
661
+190
| +40% | +$31.6K | ﹤0.01% | 2133 |
|
|
2021
Q4 | $79K | Buy |
471
+120
| +34% | +$20.1K | ﹤0.01% | 2392 |
|
|
2021
Q3 | $31K | Sell |
351
-111
| -24% | -$9.8K | ﹤0.01% | 3354 |
|
|
2021
Q2 | $25K | Buy |
462
+222
| +93% | +$12K | ﹤0.01% | 3678 |
|
|
2021
Q1 | $14K | Sell |
240
-1,425
| -86% | -$83.1K | ﹤0.01% | 4151 |
|
|
2020
Q4 | $86K | Sell |
1,665
-1,415
| -46% | -$73.1K | ﹤0.01% | 2498 |
|
|
2020
Q3 | $149K | Buy |
3,080
+2,459
| +396% | +$119K | ﹤0.01% | 2821 |
|
|
2020
Q2 | $32K | Buy |
+621
| New | +$32K | ﹤0.01% | 3401 |
|
|
2019
Q4 | – | Sell |
-127
| Closed | -$4K | – | 3981 |
|
|
2019
Q3 | $4K | Buy |
127
+123
| +3,075% | +$3.87K | ﹤0.01% | 3425 |
|
|
2019
Q2 | $0 | Sell |
4
-172
| -98% | – | ﹤0.01% | 3993 |
|
|
2019
Q1 | $31K | Buy |
176
+166
| +1,660% | +$29.2K | ﹤0.01% | 2018 |
|
|
2018
Q4 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 3381 |
|